USPTO serial 79378177
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
B. Michelle Alvey
B. Michelle Alvey Husch Blackwell LLP8001 Forsyth Boulevard, Suite 1500St. Louis, MO 63105United States| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Unprocessed chemical products, namely, unprocessed plastics, unprocessed polymers, unprocessed artificial resins; biochemical catalysts, catalysts for chemical and biochemical processes, catalysts for use in the manufacture of industrial chemicals; chemical reagents for non-medical purposes; chemical additives for use in the manufacture of pharmaceuticals, agrochemicals, cosmetics, food products, and polymers; chemical products as chemical synthesis intermediates for industrial purposes; active chemical ingredients for use in manufacture of pharmaceuticals, agrochemicals, cosmetics, food products, and polymers; hemi synthesis products, namely, semi-synthesized chemical products for use in biotechnological product development; fertilizers; chemical products as intermediates for the production of pharmaceutical, veterinary, medical and cosmetic active ingredients | ACTIVE | — |
| 003 | Purified essential oil extracts, for industrial use in the pharmaceutical, cosmetics, agrochemistry, food, and polymers industries | ACTIVE | — |
| 005 | Pharmaceutical, veterinary, sanitary products, namely, steroids, diuretic preparations, anti-inflammatory preparations, dietary supplements, nutritional supplements, diagnostic agents for medical purposes being visualization agents for use during colonoscopies, contraceptive preparations, preparations for the treatment of burns, pharmaceutical preparations for the treatment of primary biliary cirrhosis in the nature of a cholelitholytic agent, pharmaceutical preparations and substances for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, oncological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders; fungicides, herbicides, insecticides, and pesticides | ACTIVE | — |
| 040 | Contract manufacturing of pharmaceutical and chemicals and their components for third parties; contract manufacturing of pharmaceuticals, chemicals and biopharmaceuticals; custom manufacturing of vaccine adjuvants, vaccines, proteins, semi-synthetic molecules, conjugated molecules, nucleic acids, polysaccharides, and other therapeutic biomolecules; custom manufacturing on a pilot and commercial scale of vaccine adjuvants, vaccines, proteins, semi-synthetic molecules, conjugated molecules, nucleic acids, polysaccharides and other therapeutic biomolecules; custom manufacturing in the nature of processing of functional food and food ingredients; custom manufacturing in the nature of processing on pilot and commercial scale of functional food and food ingredients; custom manufacturing of chemical products, active pharmaceutical ingredients and synthetic intermediates, and agrochemical active ingredients and synthetic intermediates; custom manufacturing on a pilot and commercial scale of chemical products, active pharmaceutical ingredients and synthetic intermediates, and agrochemical active ingredients and synthetic intermediates; custom manufacturing of chemicals through chemical syntheses; processing of biochemicals through the synthesis of biological products for customers in the food, chemical, agricultural, veterinary and pharmaceutical industries; custom synthesis of intermediate products in the nature of intermediate organic products for industrial purposes for the food, chemical, agricultural, veterinary, and pharmaceutical industries; contract manufacturing of hazardous products being glycerol trinitrate, azides, explosives and other industrial chemicals for third parties; contract custom manufacturing of substitution aromates and chiral molecules for use in synthesis of products for others for third parties; preparation of galenic formulations for others, namely, custom manufacture of pharmaceuticals by pharmaceutical compounders | ACTIVE | — |
| 042 | Providing quality control, namely, analytic control and authentication services for others; conducting of technical feasibility studies; technical and scientific research and development on new and existing products, notably for the food, chemical, agricultural, veterinary, pharmaceutical industries; scientific research in the field of galenic forms, specifically for others | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 12, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 5, 2026 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jan 5, 2026 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Sep 3, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 3, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 3, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 15, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 15, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 9, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 17, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 1, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Feb 10, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 8, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 7, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 7, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 7, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 19, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 13, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 7, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 10, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 10, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 10, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 10, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 2, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 2, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 2, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 25, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Oct 6, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 3, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 2, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 14, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 13, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 12, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 9, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 8, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 7, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |